263 related articles for article (PubMed ID: 406814)
1. The biochemistry of sphingolipid storage diseases.
Sandhoff K
Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
[No Abstract] [Full Text] [Related]
2. Genetic disorders of lysosomes.
Hirschhorn R; Weissmann G
Prog Med Genet; 1976; 1():49-101. PubMed ID: 180565
[No Abstract] [Full Text] [Related]
3. Disorders of lipid metabolism.
Brady RO
Biochem Soc Symp; 1972; (35):113-27. PubMed ID: 4217183
[No Abstract] [Full Text] [Related]
4. Lysosomal storage diseases.
Glew RH; Basu A; Prence EM; Remaley AT
Lab Invest; 1985 Sep; 53(3):250-69. PubMed ID: 2993742
[No Abstract] [Full Text] [Related]
5. [Procedure for the diagnosis of sphingolipidoses or allied diseases in adult patients with neurological or psychiatric symptoms (author's transl)].
Pilz H; Heipertz R; Seidel D
Nervenarzt; 1979 Dec; 50(12):749-61. PubMed ID: 94938
[No Abstract] [Full Text] [Related]
6. [Recent advances in sphingolipidosis research].
Tamai Y; Kojima H
Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1291-303. PubMed ID: 1972585
[No Abstract] [Full Text] [Related]
7. Basic findings and current developments in sphingolipidoses.
Pilz H; Heipertz R; Seidel D
Hum Genet; 1979 Mar; 47(2):113-34. PubMed ID: 108196
[TBL] [Abstract][Full Text] [Related]
8. [Molecular bases of lipidoses].
Tamai Y
Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1735-58. PubMed ID: 6442777
[No Abstract] [Full Text] [Related]
9. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
Inui K; Wenger DA
J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
[TBL] [Abstract][Full Text] [Related]
10. [Enzyme diagnostics in lysosomal diseases with emphasis on sphingolipidoses].
Dreyfus JC; Poenaru L
Arch Fr Pediatr; 1975; 32(6):503-14. PubMed ID: 810108
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic abnormalities in diseases of sphingolipid metabolism.
Brady RO
Clin Chem; 1967 Jul; 13(7):565-77. PubMed ID: 5006481
[No Abstract] [Full Text] [Related]
12. Clinical and biochemical pathophysiology of ataxia in the sphingolipidoses.
Philippart M
Adv Neurol; 1978; 21():131-49. PubMed ID: 104554
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein catabolism in brain tissue in the lysosomal enzyme deficiency diseases.
Brunngraber EG; Davis LG; Javaid JI; Berra B
Adv Exp Med Biol; 1976; 68():31-48. PubMed ID: 820170
[No Abstract] [Full Text] [Related]
14. Lipid storage disease: Part II. Ultrastructural pathology of lipid storage cells in sphingolipidoses.
Takahashi K; Naito M
Acta Pathol Jpn; 1985 Mar; 35(2):385-408. PubMed ID: 2992227
[TBL] [Abstract][Full Text] [Related]
15. [Phenotypes in heteroglycanoses and sphingolipidoses (author's transl)].
Gehler J
Monatsschr Kinderheilkd; 1981 Nov; 129(11):610-20. PubMed ID: 6798422
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic diagnosis of sphingolipidoses.
Suzuki K
Methods Enzymol; 1987; 138():727-62. PubMed ID: 2885713
[No Abstract] [Full Text] [Related]
17. Sphingolipid metabolism in neural tissues.
Brady RO
Neurosci Res (N Y); 1969; 2(0):301-15. PubMed ID: 4950732
[No Abstract] [Full Text] [Related]
18. The liver in lipid storage disease: biochemical basis of pathogenesis and clinical features.
Brady RO; James SP; Barranger JA
Prog Liver Dis; 1982; 7():331-46. PubMed ID: 6810410
[No Abstract] [Full Text] [Related]
19. Enzymic diagnosis of sphingolipidoses.
Suzuki K
Methods Enzymol; 1978; 50():456-88. PubMed ID: 26837
[No Abstract] [Full Text] [Related]
20. Progress in investigations of sphingolipidoses.
Adachi M; Schneck L; Volk BW
Acta Neuropathol; 1978 Aug; 43(1-2):1-18. PubMed ID: 97916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
